United Therapeutics | UTHR - Nettoeinkommen

Aktienkurs
577.63
Täglich Wechseln
5.90 1.03%
Monatlich
8.11%
Jährlich
103.17%
Q2 Prognose
556.12




Nettoeinkommen Veränderung Datum
Amarin USD -1.22M 6.51M 2025-12
Ardelyx USD -407K 562K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Bayer EUR -3.76B 2.79B 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Insmed USD -328.48M 41.54M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
J&J USD 5.12B 36M 2025-12
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Moderna USD -200M 625M 2025-09
Omeros USD -32.23M 23.81M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12